Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 142-154
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.142
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.142
Table 5 Relationship of vitamin D to liver fibrosis in non-alcoholic fatty liver disease by high vs low fibrosis score
Author | (n), 25-OH(D) Mean ± SD F0-F2 | (n), 25-OH(D) Mean ± SD F3-F4 |
Patel et al[32], 2016 | (172) 26.9 ± 10.7 | (72) 29.4 ± 15.4 |
Targher et al[26], 2007 | (33) 16.6 ± 10.0 | (6) 6.0 ± 10.8 |
Anty et al[27], 2016 | (381) 19.5 ± 9.1 | (17) 17.7 ± 10.0 |
Luger et al[30], 2016 | (40) 15.2 ± 5.6 | (6) 18.6 ± 6.4 |
Bril et al[29], 2015 | (158) 22.3 ± 13.2 | (27) 24.7 ± 11.5 |
Barchetta et al[28], 2012 | (7) 20.2 ± 11.07 | (18) 26.7 ± 14.2 |
- Citation: Saberi B, Dadabhai AS, Nanavati J, Wang L, Shinohara RT, Mullin GE. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data. World J Hepatol 2018; 10(1): 142-154
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/142.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.142